Literature DB >> 21807053

Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites.

Satish Mishra1, Urvashi Rai, Takayuki Shiratsuchi, Xiangming Li, Yannick Vanloubbeeck, Joe Cohen, Ruth S Nussenzweig, Elizabeth A Winzeler, Moriya Tsuji, Victor Nussenzweig.   

Abstract

Immunization of BALB/c mice with irradiated sporozoites (IrSp) of Plasmodium yoelii can lead to sterile immunity. The circumsporozoite protein (CSP) plays a dominant role in protection. Nevertheless after hyper-immunization with IrSp, complete protection is obtained in CSP-transgenic BALB/c mice that are T-cell tolerant to the CSP and cannot produce antibodies [CSP-Tg/JhT(-/-)]. This protection is mediated exclusively by CD8(+) T cells [1]. To identify the non-CSP protective T cell antigens, we studied the properties of 34 P. yoelii sporozoite antigens that are predicted to be secreted and to contain strong Kd-restricted CD8(+) T cell epitopes. The synthetic peptides corresponding to the epitopes were used to screen for the presence of peptide-specific CD8(+) T cells secreting interferon-γ (IFN-γ) in splenocytes from CSP-Tg/JhT(-/-) BALB/c mice hyper immunized with IrSp. However, the numbers of IFN-γ-secreting splenocytes specific for the non-CSP antigen-derived peptides were 20-100 times lower than those specific for the CSP-specific peptide. When mice were immunized with recombinant adenoviruses expressing selected non-CSP antigens, the animals were not protected against challenge with P. yoelii sporozoites although large numbers of CD8(+) specific T cells were generated.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807053      PMCID: PMC3603353          DOI: 10.1016/j.vaccine.2011.07.081

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  49 in total

1.  Malaria vaccines-targeting infected hepatocytes.

Authors:  S L Hoffman; D L Doolan
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

Review 2.  Plasmodium sporozoite molecular cell biology.

Authors:  Stefan H I Kappe; Carlos A Buscaglia; Victor Nussenzweig
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

3.  Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS.

Authors:  Elke S Bergmann-Leitner; Patricia M Legler; Tatyana Savranskaya; Christian F Ockenhouse; Evelina Angov
Journal:  Vaccine       Date:  2011-06-29       Impact factor: 3.641

4.  Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon.

Authors:  A Ferreira; L Schofield; V Enea; H Schellekens; P van der Meide; W E Collins; R S Nussenzweig; V Nussenzweig
Journal:  Science       Date:  1986-05-16       Impact factor: 47.728

5.  Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria.

Authors:  F Zavala; J P Tam; M R Hollingdale; A H Cochrane; I Quakyi; R S Nussenzweig; V Nussenzweig
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

6.  Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei.

Authors:  R S Nussenzweig; J Vanderberg; H Most; C Orton
Journal:  Nature       Date:  1967-10-14       Impact factor: 49.962

7.  Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

Authors:  Stephen L Hoffman; Lucy M L Goh; Thomas C Luke; Imogene Schneider; Thong P Le; Denise L Doolan; John Sacci; Patricia de la Vega; Megan Dowler; Chris Paul; Daniel M Gordon; Jose A Stoute; L W Preston Church; Martha Sedegah; D Gray Heppner; W Ripley Ballou; Thomas L Richie
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

8.  Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.

Authors:  Denise L Doolan; Scott Southwood; Daniel A Freilich; John Sidney; Norma L Graber; Lori Shatney; Lolita Bebris; Laurence Florens; Carlota Dobano; Adam A Witney; Ettore Appella; Stephen L Hoffman; John R Yates; Daniel J Carucci; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-28       Impact factor: 11.205

9.  Biosynthesis of Pb44, the protective antigen of sporozoites of Plasmodium berghei.

Authors:  N Yoshida; P Potocnjak; V Nussenzweig; R S Nussenzweig
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

10.  Discovery of gene function by expression profiling of the malaria parasite life cycle.

Authors:  Karine G Le Roch; Yingyao Zhou; Peter L Blair; Muni Grainger; J Kathleen Moch; J David Haynes; Patricia De La Vega; Anthony A Holder; Serge Batalov; Daniel J Carucci; Elizabeth A Winzeler
Journal:  Science       Date:  2003-07-31       Impact factor: 47.728

View more
  14 in total

1.  Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.

Authors:  Charles S Rosenberg; Weibo Zhang; Juan M Bustamante; Rick L Tarleton
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

2.  A T-cell response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations.

Authors:  Sean C Murphy; Arnold Kas; Brad C Stone; Michael J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

Review 3.  Pre-erythrocytic malaria vaccines: identifying the targets.

Authors:  Patrick E Duffy; Tejram Sahu; Adovi Akue; Neta Milman; Charles Anderson
Journal:  Expert Rev Vaccines       Date:  2012-10       Impact factor: 5.217

4.  Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice.

Authors:  Krystelle Nganou-Makamdop; Maarten L van Roosmalen; Sandrine A L Audouy; Geert-Jan van Gemert; Kees Leenhouts; Cornelus C Hermsen; Robert W Sauerwein
Journal:  Malar J       Date:  2012-02-20       Impact factor: 2.979

5.  Antigen-driven focal inflammatory death of malaria liver stages.

Authors:  Ganchimeg Bayarsaikhan; Masoud Akbari; Katsuyuki Yui; Rogerio Amino
Journal:  Front Microbiol       Date:  2015-02-04       Impact factor: 5.640

6.  Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development.

Authors:  Joao C Aguiar; Jessica Bolton; Joyce Wanga; John B Sacci; Hideyuki Iriko; Julie K Mazeika; Eun-Taek Han; Keith Limbach; Noelle B Patterson; Martha Sedegah; Ann-Marie Cruz; Takafumi Tsuboi; Stephen L Hoffman; Daniel Carucci; Michael R Hollingdale; Eileen D Villasante; Thomas L Richie
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

Review 7.  The case for a rational genome-based vaccine against malaria.

Authors:  Carla Proietti; Denise L Doolan
Journal:  Front Microbiol       Date:  2015-01-22       Impact factor: 5.640

8.  Identification of pre-erythrocytic malaria antigens that target hepatocytes for killing in vivo and contribute to protection elicited by whole-parasite vaccination.

Authors:  Lin Chen; Gladys J Keitany; Xiaohong Peng; Claire Gibson; Isaac Mohar; Marissa Vignali; Ian N Crispe; Fusheng Huang; Ruobing Wang
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

9.  Identification of targets of CD8⁺ T cell responses to malaria liver stages by genome-wide epitope profiling.

Authors:  Julius Clemence R Hafalla; Karolis Bauza; Johannes Friesen; Gloria Gonzalez-Aseguinolaza; Adrian V S Hill; Kai Matuschewski
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

10.  A New Method to Determine Antigen-Specific CD8+ T Cell Activity in Vivo by Hydrodynamic Injection.

Authors:  Urvashi Rai; Jing Huang; Satish Mishra; Xiangming Li; Takayuki Shiratsuchi; Moriya Tsuji
Journal:  Biomolecules       Date:  2012-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.